Search our Database of Scientific Publications and Authors

I’m looking for a
    Melatonin inhibits serotonin transporter activity in intestinal epithelial cells.
    J Pineal Res 2010 May 4;48(4):332-9. Epub 2010 Mar 4.
    Departamento de Farmacología y Fisiología, Universidad de Zaragoza, Spain.
    Gastrointestinal serotonin (5-HT) and melatonin are two closely related neuromodulators which are synthesised in the enterochromaffin cells of the intestinal epithelium and which have been shown to be involved in the physiopathology of the gastrointestinal tract. The effects of 5-HT depend on 5-HT availability which is, in part, modulated by the serotonin transporter (SERT). This transporter provides an efficient 5-HT uptake after release and is expressed in the membrane of the enterocytes. Although the origin and effects of 5-HT and melatonin are similar, the interrelationship between them in the gastrointestinal tract is unknown. The main aim of this study was to determine whether melatonin affects SERT activity and expression, and, if so, to elucidate the mechanisms involved. Caco-2 cell line was used to carry out the study as these cells have been shown to endogenously express SERT. The results showed that melatonin inhibits SERT activity by affecting both V(max) and kt kinetic constants although SERT synthesis or intracellular trafficking did not appear to be affected. The melatonin effect seemed to be independent of melatonin receptors MT(1) and MT(2) and protein kinase C and cAMP intracellular pathways. Our results suggest that the inhibition of SERT might be due to a catalytic effect of melatonin on the allosteric citalopram-sensitive site in SERT. This study shows, for the first time, that melatonin modulates SERT activity, thus demonstrating the feedback system between melatonin and the serotoninergic system in the gastrointestinal tract.

    Similar Publications

    Lipopolysaccharide induces alteration of serotonin transporter in human intestinal epithelial cells.
    Innate Immun 2009 Aug 8;15(4):243-50. Epub 2009 Jul 8.
    Department of Pharmacology and Physiology, Faculty of Veterinary Sciences, University of Zaragoza, Zaragoza, Spain.
    Intestinal serotoninergic activity and serotonin transporter (SERT) function have been shown to be altered in intestinal inflammatory diseases. Serotonin (5-HT) plays a critical role in the regulation of gastrointestinal physiology. Activity of 5-HT depends on its extracellular availability, partly modulated by SERT that transports 5-HT into the cell. Read More
    Regulation of serotonin transporter activity by adenosine in intestinal epithelial cells.
    Biochem Pharmacol 2009 Nov 17;78(9):1198-204. Epub 2009 Jun 17.
    Department of Pharmacology and Physiology, Faculty of Veterinary Sciences, University of Zaragoza, Miguel Servet 177, Zaragoza, Spain.
    Serotonin plays a critical role in the regulation of intestinal physiology. The serotonin transporter (SERT) expressed in the intestinal epithelium determines 5-HT availability and activity. The serotoninergic system and SERT activity have been described as being altered in chronic intestinal pathologies such as inflammatory diseases. Read More
    Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells.
    Acta Physiol (Oxf) 2008 May 14;193(1):57-65. Epub 2007 Dec 14.
    Division of Physiology, Department of Pharmacology and Physiology, Faculty of Veterinary Sciences, Zaragoza University, Zaragoza, Spain.
    Aim: The aim of this study was to determine the effect of long-term serotonin (5-hydroxytryptamine, 5-HT) treatment on the human serotonin transporter (hSERT) function and its expression.

    Methods: This study was carried out in the enterocyte-like cell line Caco-2. These cells constitutively express the hSERT and have been shown to be an excellent model for the study of this protein. Read More
    Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells.
    Life Sci 2007 Mar 20;80(16):1517-24. Epub 2007 Jan 20.
    Department of Pharmacology and Physiology, Physiology, University of Zaragoza, Zaragoza, Spain.
    Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) broadly used in the treatment of human mood disorders and gastrointestinal diseases involving the serotoninergic system. The effectiveness of this therapy depends on repeated long-term treatment. Most of the long-term studies in vivo of SSRI effects on serotoninergic activity have focused on their effects on autoreceptors or postsynaptic receptors. Read More